Sign In
Buy AMRN
$14.53
+0.0600 (+0.415%)
At Close: Jun 03, 2026
Amarin Reports First Quarter 2021 Financial Results and Provides Business Update
06:10am, Thursday, 29'th Apr 2021
Commercial Launch of VAZKEPA in Europe on Track to Commence in Q3 2021 Following Recent Market Authorization with VASCEPA® Growth in the United States Positioned to Increase as the Impact of COVID-19
Amarin Announces Planned Retirement of Joseph T. Kennedy, EVP, General Counsel
06:00am, Thursday, 29'th Apr 2021
DUBLIN, Ireland and BRIDGEWATER, N.J., April 29, 2021 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), today announced that Joseph T. Kennedy has informed the board of directors of his decisi
VAZKEPA (icosapent ethyl) is the first and only authorized treatment for its cardiovascular risk reduction indication 1,2, 3
Amarin to Report First Quarter Results and Host Conference Call on April 29, 2021
06:05am, Tuesday, 20'th Apr 2021
DUBLIN, Ireland and BRIDGEWATER, N.J., April 20, 2021 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with members of Amarin senior managem
Study quantified coronary plaque changes in patients administered 4 g/day of VASCEPA® (icosapent ethyl) on top of statin therapy
With Their European Approval In Hand, Amarin Signals A Strategic Shift With A New CEO
05:45pm, Tuesday, 13'th Apr 2021
Amarin received approval to market their drug Vascepa in Europe, but the market shrugged off the news and sent shares lower. As the company struggles with sales and legal battles, a new CEO has been h
Why Amarin Stock Is Sinking Today
11:39am, Tuesday, 13'th Apr 2021
The company's CEO announced his retirement.
AMRN Stock: Over 4% Decrease Pre-Market Explanation
08:40am, Tuesday, 13'th Apr 2021
The stock price of Amarin Corporation plc (Nasdaq: AMRN) fell by over 4% pre-market. This is why it happened.
Amarin Announces CEO Succession Plan
04:30pm, Monday, 12'th Apr 2021
John Thero to Retire as President and CEO on August 1, 2021
3 Top Healthcare Stocks to Buy in April
06:40am, Saturday, 10'th Apr 2021
All three companies have enjoyed major growth catalysts since the start of 2021.
Should You Buy Amarin in April?
07:33am, Friday, 09'th Apr 2021
This biotech's heart medication could be wildly lucrative.
Reimbursement dossiers for first 10 countries to be filed in coming months
Why Amarin Stock Was a Winner Today
05:22pm, Tuesday, 30'th Mar 2021
The company won crucial regulatory approval in a massive new market.
Amarin Stock Is Trading Higher After EU Approval For Icosapent Ethyl
07:16am, Tuesday, 30'th Mar 2021
The European Commission (EC) has approved the marketing authorization application for Amarin Corporation Plc's (NASDAQ: AMRN) Vazkepa (icosapent ethyl) for cardiovascular risk reduction. The appr
AMRN Stock Price Increased Over 5% Pre-Market: Why It Happened
07:07am, Tuesday, 30'th Mar 2021
The stock price of Amarin Corporation plc (NASDAQ: AMRN) increased by over 5% pre-market. This is why it happened.
